13.06.2017
- US drugmaker Merck has signed a partnership agreement with UK biotech F-star to develop and commercialize five of the Cambridge-headquartered company’s novel bispecific immuno...
25.05.2017
- The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
04.01.2017
- Sanofi Pasteur, the global vaccines business unit of French drugmaker Sanofi, and Merck, Sharp and Dohme, international arm of US drugmaker Merck. have ended their vaccine joint...
20.12.2016
- Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...
07.05.2015
- An investment in process analytical technology (PAT) is not just a capital investment, but also an investment in human resources and a commitment to change fundamental processes...
28.10.2013
- Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...
19.04.2011
- Merck & Co., known as MSD outside the United States and Canada, announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00...
